LYRApCFRANK

Base Information

Chemical Name:LYRApCFRANK
CAS No.:1356006-93-3
Molecular Formula:C₆₀H₉₅N₁₉O₁₄S
Molecular Weight:1338.6
Hs Code.:

Synonyms:

Suppliers and Price of LYRApCFRANK

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of LYRApCFRANK

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of LYRApCFRANK

There total 1 articles about LYRApCFRANK which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

: 13139-15-6,53296-34-7
N-tert-butoxycarbonyl-L-leucine

: 15761-38-3
L-N-Boc-Ala

: 13734-34-4
N-tert-butoxycarbonyl-L-phenylalanine

: Boc-Cys(4-MeBzl)-OH

: 13836-37-8
Boc-Arg(Tos)-OH

: 54613-99-9
Boc-(S)-Lys(2-Cl-Z)-OH

: 47689-67-8
(S)-3-[4-(2-Bromo-benzyloxycarbonyloxy)-phenyl]-2-tert-butoxycarbonylamino-propionic acid

: 65420-40-8
(S)-2-tert-Butoxycarbonylamino-N-(9H-xanthen-9-yl)-succinamic acid

: 37784-17-1,59433-50-0
N-(tert-butoxycarbonyl)-D-proline

: 1356006-93-3
LYRApCFRANK

Guidance literature:: Boc-(S)-Lys(2-Cl-Z)-OH; With HO-CH₂-Pam-polystyrene resin; solid phase reaction;

solid phase reaction;

N-tert-butoxycarbonyl-L-leucine; L-N-Boc-Ala; N-tert-butoxycarbonyl-L-phenylalanine; Boc-Cys(4-MeBzl)-OH; Boc-Arg(Tos)-OH; (S)-3-[4-(2-Bromo-benzyloxycarbonyloxy)-phenyl]-2-tert-butoxycarbonylamino-propionic acid; (S)-2-tert-Butoxycarbonylamino-N-(9H-xanthen-9-yl)-succinamic acid; N-(tert-butoxycarbonyl)-D-proline; Further stages;
DOI:10.1002/anie.201105512